Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T13:26:50.818Z.
Calculation as of: 2026-10-06T13:26:50.818Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 57b29b385eb1f41c31df3b51fd673e34c67ab99ff5acc6fa5376275c9290a164
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-11.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$70.01M
EV/EBITDA Ratio
N/A
TTM Avg
161.81x
3Y Avg
161.81x
5Y Avg
161.81x
Market Cap
$69.05M
EV/EBITDA Ratio
260.01x
TTM Avg
103.53x
3Y Avg
75.29x
5Y Avg
64.49x
Market Cap
$67.11M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | $70.03M | N/A | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $70.01M | N/A | 161.81x | 161.81x | 161.81x |
| Fortress Biotech, Inc. (FBIO)vs › | $69.43M | N/A | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | 260.01x | 103.53x | 75.29x | 64.49x |
| iBio, Inc. (IBIO)vs › | $72.02M | N/A | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $72.09M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $67.11M | N/A | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $64.90M | N/A | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $74.35M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-05-11 | 676.42x |
| 2026-05-08 | 782.31x |
| 2026-05-07 | 794.78x |
| 2026-05-06 | 823.88x |
| 2026-05-05 | 790.62x |
| 2026-05-04 | 786.47x |
| 2026-05-01 | 807.25x |
| 2026-04-30 | 778.15x |
| 2026-04-29 | 774.00x |
| 2026-04-28 | 782.31x |
| 2026-04-27 | 774.00x |
| 2026-04-24 | 774.00x |
| 2026-04-23 | 694.92x |
| 2026-04-22 | 703.32x |
| 2026-04-21 | 703.32x |
| 2026-04-20 | 715.79x |
| 2026-04-17 | 695.01x |
| 2026-04-16 | 670.06x |
| 2026-04-15 | 677.01x |
| 2026-04-14 | 668.86x |
| 2026-04-13 | 656.22x |
| 2026-04-10 | 633.90x |
| 2026-04-09 | 619.93x |
| 2026-04-08 | 625.17x |
| 2026-04-07 | 607.46x |
| 2026-04-06 | 616.23x |
| 2026-04-02 | 611.53x |
| 2026-04-01 | 613.32x |
| 2026-03-31 | 611.90x |
| 2026-03-30 | 589.37x |
| 2026-03-27 | 605.09x |
| 2026-03-26 | 622.30x |
| 2026-03-25 | 610.32x |
| 2026-03-24 | 597.10x |
| 2026-03-23 | 611.70x |
| 2026-03-20 | 602.97x |
| 2026-03-19 | 619.05x |
| 2026-03-18 | 628.49x |
| 2026-03-17 | 639.42x |
| 2026-03-16 | 652.27x |
| 2026-03-13 | 645.83x |
| 2026-03-12 | 665.03x |
| 2026-03-11 | 682.54x |
| 2026-03-10 | 690.10x |
| 2026-03-09 | 693.55x |
| 2026-03-06 | 681.12x |
| 2026-03-05 | 703.32x |
| 2026-03-04 | 749.05x |
| 2026-03-03 | 757.37x |
| 2026-03-02 | 778.15x |
| 2026-02-27 | 774.00x |
| 2026-02-26 | 76.31x |
| 2026-02-25 | 71.14x |
| 2026-02-24 | 71.57x |
| 2026-02-23 | 75.88x |
| 2026-02-20 | 75.45x |
| 2026-02-19 | 75.88x |
| 2026-02-18 | 76.74x |
| 2026-02-17 | 75.88x |
| 2026-02-13 | 74.15x |
| 2026-02-12 | 74.15x |
| 2026-02-11 | 75.01x |
| 2026-02-10 | 79.32x |
| 2026-02-09 | 79.75x |
| 2026-02-06 | 78.89x |
| 2026-02-05 | 76.74x |
| 2026-02-04 | 81.48x |
| 2026-02-03 | 83.63x |
| 2026-02-02 | 84.06x |
| 2026-01-30 | 81.48x |
| 2026-01-29 | 82.34x |
| 2026-01-28 | 81.91x |
| 2026-01-27 | 84.92x |
| 2026-01-26 | 86.64x |
| 2026-01-23 | 85.78x |
| 2026-01-22 | 87.07x |
| 2026-01-21 | 87.51x |
| 2026-01-20 | 85.78x |
| 2026-01-16 | 88.80x |
| 2026-01-15 | 88.80x |
| 2026-01-14 | 88.80x |
| 2026-01-13 | 88.37x |
| 2026-01-12 | 88.80x |
| 2026-01-09 | 84.49x |
| 2026-01-08 | 79.32x |
| 2026-01-07 | 78.89x |
| 2026-01-06 | 77.17x |
| 2026-01-05 | 78.03x |
| 2026-01-02 | 78.89x |
| 2025-12-31 | 80.61x |
| 2025-12-30 | 82.77x |
| 2025-12-29 | 81.04x |
| 2025-12-26 | 79.75x |
| 2025-12-24 | 79.75x |
| 2025-12-23 | 79.75x |
| 2025-12-22 | 82.34x |
| 2025-12-19 | 80.61x |
| 2025-12-18 | 80.18x |
| 2025-12-17 | 79.32x |
| 2025-12-16 | 84.06x |
| 2025-12-15 | 84.92x |
| 2025-12-12 | 83.63x |
| 2025-12-11 | 83.63x |
| 2025-12-10 | 83.63x |
| 2025-12-09 | 81.91x |
| 2025-12-08 | 82.77x |
| 2025-12-05 | 81.04x |
| 2025-12-04 | 81.04x |
| 2025-12-03 | 79.32x |
| 2025-12-02 | 75.01x |
| 2025-12-01 | 74.15x |
| 2025-11-28 | 74.58x |
| 2025-11-26 | 72.86x |
| 2025-11-25 | 71.57x |
| 2025-11-24 | 73.29x |
| 2025-11-21 | 70.28x |
| 2025-11-20 | 70.28x |
| 2025-11-19 | 71.57x |
| 2025-11-18 | 72.86x |
| 2025-11-17 | 71.57x |
| 2025-11-14 | 72.00x |
| 2025-11-13 | 72.43x |
| 2025-11-12 | 72.43x |
| 2025-11-11 | 74.58x |
| 2025-11-10 | 72.43x |
| 2025-11-07 | 72.00x |
| 2025-11-06 | 72.00x |
| 2025-11-05 | 72.43x |
| 2025-11-04 | 94.43x |
| 2025-11-03 | 96.17x |
| 2025-10-31 | 95.30x |
| 2025-10-30 | 94.43x |
| 2025-10-29 | 95.73x |
| 2025-10-28 | 96.60x |
| 2025-10-27 | 96.17x |
| 2025-10-24 | 97.03x |
| 2025-10-23 | 96.60x |
| 2025-10-22 | 96.60x |
| 2025-10-21 | 101.36x |
| 2025-10-20 | 103.53x |
| 2025-10-17 | 100.93x |
| 2025-10-16 | 101.36x |
| 2025-10-15 | 103.53x |
| 2025-10-14 | 102.23x |
| 2025-10-13 | 101.36x |
| 2025-10-10 | 100.50x |
| 2025-10-09 | 101.80x |
| 2025-10-08 | 103.53x |
| 2025-10-07 | 102.23x |
| 2025-10-06 | 103.10x |
| 2025-10-03 | 102.23x |
| 2025-10-02 | 101.36x |
| 2025-10-01 | 99.20x |
| 2025-09-30 | 99.63x |
| 2025-09-29 | 100.07x |
| 2025-09-26 | 97.47x |
| 2025-09-25 | 97.90x |
| 2025-09-24 | 99.20x |
| 2025-09-23 | 98.77x |
| 2025-09-22 | 101.36x |
| 2025-09-19 | 98.33x |
| 2025-09-18 | 100.93x |
| 2025-09-17 | 97.47x |
| 2025-09-16 | 98.77x |
| 2025-09-15 | 98.77x |
| 2025-09-12 | 99.63x |
| 2025-09-11 | 100.50x |
| 2025-09-10 | 100.07x |
| 2025-09-09 | 101.36x |
| 2025-09-08 | 101.36x |
| 2025-09-05 | 101.80x |
| 2025-09-04 | 102.23x |
| 2025-09-03 | 102.66x |
| 2025-09-02 | 102.23x |
| 2025-08-29 | 103.53x |
| 2025-08-28 | 105.26x |
| 2025-08-27 | 103.96x |
| 2025-08-26 | 106.13x |
| 2025-08-25 | 104.83x |
| 2025-08-22 | 105.70x |
| 2025-08-21 | 102.23x |
| 2025-08-20 | 101.36x |
| 2025-08-19 | 100.93x |
| 2025-08-18 | 101.36x |
| 2025-08-15 | 102.66x |
| 2025-08-14 | 103.53x |
| 2025-08-13 | 105.70x |
| 2025-08-12 | 101.80x |
| 2025-08-11 | 100.50x |
